Literature DB >> 728297

Protein binding of atenolol and propranolol to human serum albumin and in human plasma [proceedings].

H E Barber, G M Hawksworth, N R Kitteringham, J Petersen, J C Petrie, J M Swann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728297

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Evaluation of clinical bradycardiac effect and respiratory adverse effect of β-blocking agents in coronary computed tomography angiography based on theoretical analysis.

Authors:  Kaori Fujito; Risa Takayanagi; Koji Kimura; Haruko Yokoyama; Yasuhiko Yamada
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-16       Impact factor: 2.441

2.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 3.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

4.  A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.

Authors:  J W Rigby; A K Scott; G M Hawksworth; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

5.  Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.

Authors:  E A Taylor; D Jefferson; J D Carroll; P Turner
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

6.  Atenolol in the treatment of pregnancy-induced hypertension.

Authors:  K J Thorley; J McAinsh; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

7.  The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.

Authors:  E A Taylor; P Turner
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of atenolol--a review.

Authors:  W Kirch; K G Görg
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

9.  Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.

Authors:  I D Bradbrook; M Babiker; P Crome; H C Gillies; P J Morrison; H J Rogers; P Shotton
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

10.  Depolarization-induced release of propranolol and atenolol from rat cortical synaptosomes.

Authors:  P S Bright; T E Gaffney; J A Street; J G Webb
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.